The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAura Egy Regulatory News (AURA)

Share Price Information for Aura Egy (AURA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.75
Bid: 9.50
Ask: 10.00
Change: 0.00 (0.00%)
Spread: 0.50 (5.263%)
Open: 9.75
High: 9.75
Low: 9.75
Prev. Close: 9.75
AURA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

17 Mar 2021 07:45

RNS Number : 5421S
Aura Energy Limited
17 March 2021
 

17 March 2021

 

 

AURA ENERGY LIMITED

("Aura" or the "Company")

Results of Annual General Meeting

 

The Company wishes to advise that all Resolutions contained in the Notice of Meeting were carried by poll with the exception of Resolution 2 on Conditional Spill.

 

In accordance with ASX Listing rule 3.13.2 and Section 251AA(1) of the Corporations Act 2001, the following link provides information in relation to the proxy votes received for each Resolution considered by Members of the Company at the Annual General Meeting held today.

 

http://www.rns-pdf.londonstockexchange.com/rns/5421S_1-2021-3-17.pdf

 

Resolution 1 required 75% approval to be passed. This threshold has been achieved and these resolutions passed.

 

 

Aura Energy Limited

Peter Reeve (CEO)

 

SP Angel Corporate Finance LLP

(Nominated Advisor and Joint Broker)

Ewan Leggat

Caroline Rowe

 

WH Ireland Limited

(Joint Broker)

Adrian Hadden

James Sinclair-Ford

 

 

Yellow Jersey PR Limited

Felicity Winkles

Joe Burgess

 

Telephone: +61 (3) 9516 6500

info@auraenergy.com.au

 

Telephone: +44 (0) 203 470 0470

 

 

 

 

 

Telephone: +44 (0) 207 220 1666

 

 

 

 

 

Telephone: +44 (0) 7769 325 254

 

 

The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014.

Martin Rogers - Non-Executive Chairman

The following information is disclosed pursuant to Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies in relation to Martin Frederick Rogers, aged 40:

 Current directorships and/or partnerships:

Former directorships and/or partnerships (within the last five years):

 

KTM Ventures Innovation Fund LP

SpringCapital

Bitcoin Access

 

Independent Reserve

Identitii

Actinogen Medical

OncoSil Medical

 

 

As at the date of this announcement, Mr. Rogers does not hold any shares in the Company although following the issue of shares and options as proposed and passed at the AGM, Mr. Rogers will hold 50,000,000 shares on a pre-Consolidation basis, or 3,846,554 shares on a post-Consolidation basis. Mr. Rogers will also hold 200,000,000 options on a pre-Consolidation basis, or 15,384,616 options on a post-Consolidation basis.

These options will be exercisable at A$0.004 each on a pre-Consolidation basis, or A$0.052 each (on a post-Consolidation basis), on or before 30 June 2024.

Peter Ward - Non-Executive Director

 The following information is disclosed pursuant to Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies in relation to Peter Daniel Ward, aged 51:

No current directorships or previous directorships within the last five years are held by Mr. Ward.

As at the date of this announcement, Mr. Ward holds 3,000,000 shares in the Company although following the issue of shares and options as proposed and passed at the AGM, Mr. Ward will hold 28,000,000 shares on a pre-Consolidation basis, or 2,153,846 shares on a post-Consolidation basis. Mr. Ward will also hold 75,000,000 options on a pre-Consolidation basis, or 5,769,230 options on a post-Consolidation basis.

These options will be exercisable at A$0.004 each on a pre-Consolidation basis, or A$0.052 each (on a post-Consolidation basis), on or before 30 June 2024.

There are no further disclosures required under Schedule 2(g) of the AIM Rules for Companies. 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGDKOBQOBKKNND
Date   Source Headline
30th Sep 20229:38 amRNSIssue of Equity
23rd Sep 20227:47 amRNSHolding(s) in Company
21st Sep 20229:32 amRNSHolding(s) in Company
19th Sep 20227:21 amRNSDavid Woodall Appointed as MD & CEO
12th Sep 20228:42 amRNSIssue of Equity
9th Sep 20228:22 amRNSHolding(s) in Company
6th Sep 20227:00 amRNSSUBMISSION OF EXPORT PRIOR AUTHORISATION
30th Aug 202211:51 amRNSHolding(s) in Company
25th Aug 20227:55 amRNSHolding(s) in Company
1st Aug 20228:12 amRNSHolding(s) in Company
1st Aug 20227:00 amRNSTotal Voting Rights
29th Jul 20227:42 amRNSQuarterly Report for Period Ending 30 June 2022
20th Jul 20228:46 amRNSIssue of Equity
19th Jul 202211:10 amRNSIssue of Equity
1st Jul 20229:40 amRNSLoan Funded Shares and Total Voting Rights
30th Jun 20227:00 amRNSCAPEX AND OPEX ENGINEERING OPTIMISATION COMMENCED
29th Jun 202211:07 amRNSHolding(s) in Company
27th Jun 20227:00 amRNSHolding(s) in Company
23rd Jun 20227:00 amRNSPilot Tests at Tiris Uranium Project
27th May 20227:00 amRNSDrilling for the Tiris Uranium Resource Upgrade
23rd May 20227:00 amRNSIssue of Equity
18th May 20227:00 amRNSUranium Specialist Patrick Mutz Joins Aura Board
12th May 20224:42 pmRNSSecond Price Monitoring Extn
12th May 20224:36 pmRNSPrice Monitoring Extension
5th May 20227:00 amRNSNew Corporate Presentation
3rd May 20227:40 amRNSIssue of Equity
27th Apr 20227:42 amRNSQuarterly Report for the Period Ending 31 March 22
21st Apr 20227:52 amRNSIssue of Equity
19th Apr 20227:00 amRNSUranium Resource Upgrade Programme Underway
6th Apr 202210:12 amRNSIssue of Equity
1st Apr 20227:00 amRNSIssue of Loan Funded Shares
25th Mar 20227:00 amRNSSupplement to 31 December 2021 Half Year Report
23rd Mar 20229:56 amRNSIssue of Equity
17th Mar 20227:41 amRNSIssue of Equity
17th Mar 20227:30 amRNSCleansing Prospectus
14th Mar 20227:00 amRNSFirm commitments for A$8.8 million placement
9th Mar 20227:52 amRNSASX Trading Halt
8th Mar 20228:12 amRNSHalf-year Report
8th Mar 20227:55 amRNSInvestor Webinar
4th Mar 20229:18 amRNSIssue of Equity
1st Mar 202210:17 amRNSMedia Release
17th Feb 20228:56 amRNSIssue of Equity
16th Feb 20227:00 amRNSInvestor Presentation
16th Feb 20227:00 amRNSAura Defines Vanadium JORC Resource
14th Feb 20227:00 amRNSGlobal X Uranium ETF Add Aura Energy
9th Feb 20227:00 amRNSTiris Uranium Resource Enhancement Programme
1st Feb 20229:36 amRNSIssue of Equity
28th Jan 20227:04 amRNSQuarterly Report
27th Jan 20227:00 amRNSNet Zero Emission Study
20th Jan 20227:00 amRNSChairman’s Letter

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.